Cover image of the article: Generation of global Spata19 knockout mouse using CRISPR/Cas9 nickase technology

Image Credit:Koomesh

Generation of global Spata19 knockout mouse using CRISPR/Cas9 nickase technology

Authors

Mahsa Zargar, Abbas Jamshidizad, Aidin RahimTayefeh, Ehsan Hashemi, Ali Najafi, Mehdi Shamsara,*, mohammad hossein modarressimohammad hossein modarressi ORCID
*Corresponding Author: Email: shamsam2000@gmail.com

Koomesh:Vol. 22, issue 3; 380-388
Published online:Sep 02, 2020
Article type:Research Article
Received:Jun 02, 2019
Accepted:Jan 02, 2020
How to Cite:Zargar M, Jamshidizad A, RahimTayefeh A, Hashemi E, Najafi A, et al. Generation of global Spata19 knockout mouse using CRISPR/Cas9 nickase technology. koomesh. 2020;22(3):e153192. doi:

Abstract

Introduction: SPATA19 gene is expressed in developmental stages of testis and some organs, but so far its function has only been examined in the testis. In this study, we provided an effective pathway for the generation of these mice using new CRISPR / Cas9 nickase method while generating Spata19 knockout mice for future studies in other organs. Materials and Methods: CRISPR / Cas9 nickase plasmids were synthesized using pX335 vector and designed gRNAs. So, each plasmid was transformed into E.coli and clonal selection was performed. The plasmids extracted from the bacteria were mixed in equal proportions and injected into the male pronucleus. Correspondingly, the zygotes carrying the plasmid were transferred to Oviduct of Foster mice. After pregnancy extent, born mice were analyzed. Results: We generated global knockout mice using CRISPR/Cas9 nickase technology. This deletion was examined at three levels of DNA, RNA and protein. Generated 2 nucleotides deletion was confirmed by sequencing at three levels of DNA, RNA and protein. By translating the mutated RNA sequence, it was determined that this deletion could cause premature stop codon. Phenotypic analysis confirmed infertility of male homozygous mice (Spata19 -/-). Conclusion: By generating Spata19 knockout mice, we present a protocol for generation of knockout mice. These mice could be applied as the infertile male mice and also for further characterization of Spata19 gene.  

Highlights

References

  • 1.
    Nourashrafeddin S, EbrahimzadehVesal R, Miryounesi M, Aarabi M, Zarghami N, Modarressi MH, Nouri M. Analysis of SPATA 19 gene expression during male germ cells development, lessons from in vivo and in vitro study. Cell Biol Int Rep 2014; 21: 1-7.
  • 2.
    Doiguchi M, Yamashita H, Ichinose J, Mori T, Shibata Y, Iida H. Complementary DNA cloning and characterization of rat spergen-1, a spermatogenic cell-specific gene-1, containing a mitochondria-targeting signal. Biol Reprod 2002; 66: 1462-1470.
  • 3.
    Babatunde KA, Najafi A, Salehipour P, Modarressi MH, Mobasheri MB. Cancer/Testis genes in relation to sperm biology and function. Iran J Basic Med Sci 2017; 20: 967-974.
  • 4.
    Suzuki-Toyota F, Ito C, Toyama Y, Maekawa M, Yao R, Noda T, et al. Factors maintaining normal sperm tail structure during epididymal maturation studied in Gopc/ mice. Biol Reprod 2007; 77: 71-82.
  • 5.
    Mi Y, Shi Z, Li J. Spata19 is critical for sperm mitochondrial function and male fertility. Mol Reprod Dev 2015; 82: 907-913.
  • 6.
    Ghafouri-Fard S, Ousati Ashtiani Z, Sabah Golian B, Hasheminasab SM, Modarressi MH. Expression of two testis-specific genes, SPATA19 and LEMD1, in prostate cancer. Arch Med Res 2010; 41: 195-200.
  • 7.
    Ghafouri-Fard S, Abbasi A, Moslehi H, Faramarzi N, Taba Taba Vakili S, Mobasheri MB, Modarressi MH. Elevated expression levels of testisspecific genes TEX101 and SPATA19 in basal cell carcinoma and their correlation with clinical and pathological features. Br J Dermatol 2010; 162: 772-779.
  • 8.
    Jansen IE, Gibbs JR, Nalls MA, Price TR, Lubbe S, van Rooij J, et al. Establishing the role of rare coding variants in known Parkinson's disease risk loci. Neurobiol Aging 2017; 59: 220. e11-220.
  • 9.
    Szabo L, Morey R, Palpant NJ, Wang PL, Afari N, Jiang C, et al. Statistically based splicing detection reveals neural enrichment and tissue-specific induction of circular RNA during human fetal development. Genome Biol 2015; 16: 126.
  • 10.
    Hall B, Limaye A, Kulkarni AB. Overview: generation of gene knockout mice. Curr Protoc Cell Biol 2009; 44: 19.12. 1-19.12.17.
  • 11.
    Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 2014; 157: 1262-1278.
  • 12.
    Koonin EV, Makarova KS. Origins and evolution of CRISPR-Cas systems. Philos Trans R Soc Lond B Biol Sci 2019; 374: 20180087.
  • 13.
    Eskandarian Boroujeni M. Genetically modified mice - Methods, applications and outlook. Sci J Kurdistan Univ Med Sci 2019; 24: 24-44.
  • 14.
    Zangala T. Isolation of genomic DNA from mouse tails. J Vis Exp 2007; 6: e246.
  • 15.
    Miyamoto T, Sengoku K, Hasuike S, Takuma N, Hayashi H, Yamashita T, Ishikawa M. Isolation and expression analysis of the human testis-specific gene, SPERGEN-1, a spermatogenic cell-specific gene-1. J Assist Reprod Genet 2003; 20: 101-104.
  • 16.
    Austin CP, Battey JF, Bradley A, Bucan M, Capecchi M, Collins FS. et al. The knockout mouse project. Nature Genet 2004; 36: 921.
  • 17.
    Sosa MG, De Gasperi R, Elder GA. Animal transgenesis: an overview. Brain Struct Funct 2010; 214: 91-109.
  • 18.
    Fujihara Y, Ikawa M. CRISPR/Cas9-based genome editing in mice by single plasmid injection, in Methods in enzymology. Methods Enzymol 2014; 546: 319-336.
  • 19.
    Nasseri S, Nikkho B, Parsa S, Ebadifar A, Soleimani F, Rahimi K, et al. Generation of Fam83h knockout mice by CRISPR/Cas9mediated gene engineering. J Cell Biochem 2019; 120: 11033-11043.
  • 20.
    Lee H, Kim JI, Park JS, Roh JI, Lee J, Kang BC, Lee HW. CRISPR/Cas9-mediated generation of a Plac8 knockout mouse model. Lab Anim Res 2018; 34: 279-287.

Copyright

© 2020, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

30
Oct
2024
CRISPR System and Its Applications in Medicine and Stem Cell Engineering

CRISPR System and Its Applications in Medicine and Stem Cell Engineering

Arash Abdolmaleki,
Aida Nahumi,
Hediye Basharzad Seddigh,
Narges Yazdannasab,
Alireza Panahi,
Sumel Ashique
,et al.

Abdolmaleki A, Nahumi A, Basharzad Seddigh H, Yazdannasab N, Panahi A, et al. CRISPR System and Its Applications in Medicine and Stem Cell Engineering. Gene Cell Tissue. 2024;11(4):e150914. doi: https://doi.org/10.5812/gct-150914

13
Jun
2026
CRISPR/Cas9-Engineered HEK293T Cellular Model Harboring the Pathogenic CDKL5 c.172A>T Variant Recapitulates Core Molecular Phenotypes of CDKL5 Deficiency Disorder

CRISPR/Cas9-Engineered HEK293T Cellular Model Harboring the Pathogenic CDKL5 c.172A>T Variant Recapitulates Core Molecular Phenotypes of CDKL5 Deficiency Disorder

Fatemeh Faghihi,
Jafar Amani,
Milad Gholami,
Iman Salahshourifar

Faghihi F, Amani J, Gholami M, Salahshourifar I. CRISPR/Cas9-Engineered HEK293T Cellular Model Harboring the Pathogenic CDKL5 c.172A>T Variant Recapitulates Core Molecular Phenotypes of CDKL5 Deficiency Disorder. Iran J Pharm Res. 2026;25(1):e172311. doi: https://doi.org/10.5812/ijpr-172311

13
Apr
2021
Construction of PX-LmGP63 Using CRISPR-Cas9 as Primary Goal for GP63 gene Knockout in Leishmania major and Leishmanization

Construction of PX-LmGP63 Using CRISPR-Cas9 as Primary Goal for GP63 gene Knockout in Leishmania major and Leishmanization

Saeedeh Ebrahimi,
Hamzeh Alipour,
Kourosh Azizi,
Mohsen Kalantari

Ebrahimi S, Alipour H, Azizi K, Kalantari M. Construction of PX-LmGP63 Using CRISPR-Cas9 as Primary Goal for GP63 gene Knockout in Leishmania major and Leishmanization. Jundishapur J Microbiol. 2021;14(1):e112965. doi: https://doi.org/10.5812/jjm.112965

31
Jan
2023
LIMA1 Gene Knockout by CRISPR/Cas9 System Using Lentiviruses as an in Vitro Model for Reducing Cholesterol Absorption

LIMA1 Gene Knockout by CRISPR/Cas9 System Using Lentiviruses as an in Vitro Model for Reducing Cholesterol Absorption

Mahdieh Talebzadeh,
Vahid Razban,
Mahintaj Dara,
Hossein Jafari Khamirani,
Maryam Ranjbar,
Marjan Nourigorji
,et al.

Talebzadeh M, Razban V, Dara M, Jafari Khamirani H, Ranjbar M, et al. LIMA1 Gene Knockout by CRISPR/Cas9 System Using Lentiviruses as an in Vitro Model for Reducing Cholesterol Absorption. Int Cardiovasc Res J. 2022;16(4):e131422. doi:

13
Jan
2023
Targeting Caspase-3 Gene in rCHO Cell Line by CRISPR/Cas9 Editing Tool and Its Effect on Protein Production in Manipulated Cell Line

Targeting Caspase-3 Gene in rCHO Cell Line by CRISPR/Cas9 Editing Tool and Its Effect on Protein Production in Manipulated Cell Line

Amirabbas Rahimi,
Morteza Karimipoor,
Reza Mahdian,
Atefeh Alipour,
Sadi Hosseini,
Hooman Kaghazian
,et al.

Rahimi A, Karimipoor M, Mahdian R, Alipour A, Hosseini S, et al. Targeting Caspase-3 Gene in rCHO Cell Line by CRISPR/Cas9 Editing Tool and Its Effect on Protein Production in Manipulated Cell Line. Iran J Pharm Res. 2022;21(1):e130236. doi: https://doi.org/10.5812/ijpr-130236

More by these authors

Mahsa ZargarPubMedScholar
Abbas JamshidizadPubMedScholar
Aidin RahimTayefehPubMedScholar
Ehsan HashemiPubMedScholar
Ali NajafiPubMedScholar
Mehdi ShamsaraPubMedScholar
mohammad hossein modarressiPubMedScholar
Share
Cited by
Metrics
Indexed in